Current answer
Does L-ergothioneine benefit skin or protect against photoaging?
A controlled human study of an ergothioneine-rich mushroom product reported skin-related outcomes, but the formulation does not establish that isolated ergothioneine caused the result. Oral, topical, mechanistic, and multi-ingredient evidence still require separate review.
Before a full review
Profile status
Source collection and claim mapping have begun. Full extraction, cross-examination, adjudication, and human approval are incomplete.
- Direction
- Not assigned
- Evidence stage
- Not assigned
- Certainty
- Not assigned
- Human review
- Not yet started
- Search indexing
- Noindex during development
- Next gate
- Primary-source extraction
Claims being mapped
These are common versions of the topic, not findings that the site endorses. Each requires its own outcome, population, and evidence test.
- Protects skin from oxidative or ultraviolet stress
- Reduces wrinkles or uneven tone
- Improves hydration, elasticity, or barrier function
- Supports skin repair or resilience
- Protects collagen or reduces photoaging
Why this benefit has been proposed
The profile records the legitimate research rationale without treating that rationale as proof.
01
Experimental ultraviolet and oxidative-stress mechanisms make skin a plausible research area.
02
Oral and topical delivery are not interchangeable.
03
A whole mushroom or multi-ingredient result must not be attributed to one constituent without an appropriate design.
Evidence landscape
Evidence categories are kept separate so mechanistic or animal findings do not make the human evidence appear stronger.
One verified randomized trial used Pleurotus tablets that provided ergothioneine and reported skin-related measures.
No additional qualifying isolated oral or topical intervention is currently promoted into this profile.
No verified observational record has yet been selected for the skin docket.
Preclinical skin evidence has not yet completed systematic collection.
Cell and tissue findings may support plausibility but cannot establish visible or clinically meaningful photoaging benefit.
Verified records currently connected
These records have structured pages in the site database. Inclusion here identifies relevance; it is not a positive rating.
Human randomized controlled trial
Ergothioneine-rich Pleurotus skin trial
Why it is relevant: Examined skin moisturizing functions and facial conditions in healthy women.
Important boundary: The intervention was a mushroom product; its result cannot automatically be attributed to isolated ergothioneine.
Inspect the study record →Questions the full review must resolve
- What did the complete product contain?
- Which outcomes were prespecified and objectively measured?
- Were changes clinically perceptible and directly different from placebo?
- Is there independent isolated-ergothioneine replication?
Current language boundary
- “L-ergothioneine is being investigated in relation to skin health.”
- “Evidence mapping and human review are incomplete.”
- “May support skin health” only as a research hypothesis, paired with the incomplete-review status.
- Descriptions of individual studies must identify their design and principal limitations.
- Prevents skin cancer
- Reverses photoaging
- Repairs sun damage
- Clinically proven anti-wrinkle ingredient
How this becomes a completed review
- 1Preliminary Evidence Profile
Claims, evidence categories, known records, and unresolved questions are mapped.
- 2Draft Evidence Review
Primary sources are extracted and the supporting case, cross-examination, rebuttal, and working adjudication are completed.
- 3Human Review in Progress
A human reviewer checks factual accuracy, interpretation, language, and unresolved risks.
- 4Review Complete
Approval is recorded before direction, evidence stage, certainty, and final language rulings are published.
Transparency record
- Page type
- Preliminary Evidence Profile
- Created
- September 20, 2026
- Evidence status
- Mapping in progress; no verdict assigned
- Human oversight
- Human review not yet started; no review conclusion has been approved
- Search status
- Excluded from search-engine indexing and the XML sitemap during development
- Methodology
- Adversarial Evidence Review Pilot
- AI assistance
- Codex assisted with claim mapping, page structure, and drafting. AI output was not treated as a scientific source.
- Ownership and conflicts
- Published by L-Ergothioneine.com. No active affiliate product links appear on this page.
Educational information only. This preliminary profile does not diagnose, prevent, or treat disease and does not provide personalized supplement advice. Do not start, stop, or change medical care based on this page.
Read the full disclaimer →